Valuation: Bayer AG

Capitalization 37.51B 43.78B 34.3B 32.48B 60.13B 4,186B 60.61B 409B 159B 1,989B 164B 161B 6,924B P/E ratio 2026 *
16.4x
P/E ratio 2027 * 12.2x
Enterprise value 69.58B 81.22B 63.62B 60.25B 112B 7,766B 112B 759B 295B 3,690B 305B 298B 12,844B EV / Sales 2026 *
1.53x
EV / Sales 2027 * 1.42x
Free-Float
100%
Yield 2026 *
0.56%
Yield 2027 * 1.84%
1 day+0.55%
1 week+2.00%
Current month+0.34%
1 month-5.98%
3 months-16.97%
6 months+34.41%
Current year+3.16%
1 week 36.72
Extreme 36.72
39.65
1 month 35.89
Extreme 35.89
41.76
Current year 35.2
Extreme 35.2
49.78
1 year 22.6
Extreme 22.6
49.78
3 years 18.38
Extreme 18.378
54.95
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2018
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 69 01/04/2002
Director/Board Member 55 01/04/2012
Director/Board Member 66 01/04/2022
Change 5d. change 1-year change 3-years change Capi.($)
+0.55%+2.00%+72.21%-28.94% 43.68B
-0.89%+3.26%+40.69%+131.73% 906B
+0.16%+3.73%+57.69%+43.55% 555B
+1.09%+3.98%+18.78%+43.23% 368B
-0.94%-0.94%+23.89%+10.73% 326B
-0.19%+3.20%+37.10%+14.40% 289B
+0.78%+3.09%+30.74%+26.23% 285B
-0.04%+0.99%+54.36%-3.18% 280B
+0.91%+1.25%-30.88%-49.10% 208B
-0.07%+2.17%+28.20%+44.34% 182B
Average +0.32%+2.09%+33.28%+23.30% 344.21B
Weighted average by Cap. +0.40%+2.36%+34.90%+49.45%

Financials

2026 *2027 *
Net sales 45.51B 53.13B 41.62B 39.41B 72.96B 5,080B 73.55B 497B 193B 2,414B 199B 195B 8,402B 46.76B 54.58B 42.75B 40.49B 74.96B 5,219B 75.56B 510B 198B 2,480B 205B 200B 8,632B
Net income 2.14B 2.49B 1.95B 1.85B 3.42B 238B 3.45B 23.31B 9.05B 113B 9.36B 9.16B 394B 3.03B 3.53B 2.77B 2.62B 4.85B 338B 4.89B 33.02B 12.83B 160B 13.26B 12.97B 559B
Net Debt 32.07B 37.44B 29.33B 27.77B 51.41B 3,579B 51.83B 350B 136B 1,701B 140B 137B 5,920B 29B 33.85B 26.51B 25.11B 46.48B 3,236B 46.86B 316B 123B 1,538B 127B 124B 5,353B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
14/05/26 38.18 +0.55% 1,673,469
13/05/26 37.97 -1.22% 2,589,639
12/05/26 38.44 +3.67% 4,606,765
11/05/26 37.08 +0.27% 1,818,248
08/05/26 36.98 -1.20% 1,903,584
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
38.18EUR
Average target price
48.58EUR
Spread / Average Target
+27.24%

Quarterly revenue - Rate of surprise